---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-004798"
form_type: "8-K"
ticker: "MASS"
cik: "0001555279"
company_name: "908 Devices Inc."
filed_at: "2026-01-20T23:59:59+00:00"
generated_at: "2026-05-16T09:32:31.727651+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# 908 Devices Q4 revenue $17.2M (+20% YoY); FY2025 ~$56M (+17%), positive Adj. EBITDA in Q4

## Summary
- Q4 2025 revenue ~$17.2M versus $14.3M in Q4 2024, growth of ~20%.
- FY2025 revenue ~$56.0M, up ~17% from $47.7M in FY2024, at high end of guidance.
- Achieved positive Adjusted EBITDA in the fourth quarter, meeting a key goal.
- Strength from U.S. state/local channel, ramping VipIR international sales, and federal/defense customers.
- CEO cites macro tailwinds: increased fentanyl/opioid crisis funding and rising global defense budgets.

## SEC filing metadata
- accession: 0001104659-26-004798
- form_type: 8-K
- ticker: MASS
- cik: 0001555279
- company_name: 908 Devices Inc.
- filed_at: 2026-01-20T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1555279/000110465926004798/0001104659-26-004798-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1555279/000110465926004798/mass-20260120x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-004798
- JSON: https://secwatch.observer/filing/0001104659-26-004798.json
- Plain text: https://secwatch.observer/filing/0001104659-26-004798.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
